nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—Temozolomide—brain cancer	0.105	0.342	CbGbCtD
Boceprevir—CYP3A4—Lomustine—brain cancer	0.089	0.291	CbGbCtD
Boceprevir—CYP3A5—Etoposide—brain cancer	0.0552	0.18	CbGbCtD
Boceprevir—ABCB1—Etoposide—brain cancer	0.0359	0.117	CbGbCtD
Boceprevir—CTSK—skull—brain cancer	0.023	0.113	CbGeAlD
Boceprevir—CYP3A4—Etoposide—brain cancer	0.0215	0.0702	CbGbCtD
Boceprevir—CMA1—blood vessel—brain cancer	0.0147	0.0728	CbGeAlD
Boceprevir—CTSV—gonad—brain cancer	0.00625	0.0308	CbGeAlD
Boceprevir—CTSL—telencephalon—brain cancer	0.00612	0.0302	CbGeAlD
Boceprevir—CTSV—pituitary gland—brain cancer	0.0061	0.0301	CbGeAlD
Boceprevir—CTSV—medulla oblongata—brain cancer	0.00588	0.029	CbGeAlD
Boceprevir—CTSK—Osteoclast Signaling—SPP1—brain cancer	0.00571	0.0444	CbGpPWpGaD
Boceprevir—CTSV—midbrain—brain cancer	0.00538	0.0265	CbGeAlD
Boceprevir—CTSV—spinal cord—brain cancer	0.00525	0.0259	CbGeAlD
Boceprevir—CTSL—gonad—brain cancer	0.0051	0.0252	CbGeAlD
Boceprevir—CTSL—pituitary gland—brain cancer	0.00498	0.0246	CbGeAlD
Boceprevir—CTSL—medulla oblongata—brain cancer	0.00481	0.0237	CbGeAlD
Boceprevir—CTSV—endocrine gland—brain cancer	0.00472	0.0233	CbGeAlD
Boceprevir—CTSV—head—brain cancer	0.00466	0.023	CbGeAlD
Boceprevir—CMA1—endocrine gland—brain cancer	0.00451	0.0223	CbGeAlD
Boceprevir—CTSV—Degradation of the extracellular matrix—BSG—brain cancer	0.00447	0.0348	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—BSG—brain cancer	0.00447	0.0348	CbGpPWpGaD
Boceprevir—CTSL—midbrain—brain cancer	0.00439	0.0217	CbGeAlD
Boceprevir—CTSL—spinal cord—brain cancer	0.00429	0.0212	CbGeAlD
Boceprevir—CTSV—central nervous system—brain cancer	0.00426	0.021	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—BSG—brain cancer	0.00416	0.0323	CbGpPWpGaD
Boceprevir—CTSS—telencephalon—brain cancer	0.00404	0.0199	CbGeAlD
Boceprevir—CTSL—endocrine gland—brain cancer	0.00386	0.019	CbGeAlD
Boceprevir—CTSK—gonad—brain cancer	0.00385	0.019	CbGeAlD
Boceprevir—CTSL—head—brain cancer	0.00381	0.0188	CbGeAlD
Boceprevir—CTSK—pituitary gland—brain cancer	0.00375	0.0185	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—PTCH1—brain cancer	0.00375	0.0292	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—BSG—brain cancer	0.0037	0.0288	CbGpPWpGaD
Boceprevir—CTSK—medulla oblongata—brain cancer	0.00362	0.0179	CbGeAlD
Boceprevir—CTSL—central nervous system—brain cancer	0.00348	0.0172	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TRPC6—brain cancer	0.00347	0.027	CbGpPWpGaD
Boceprevir—CTSL—cerebellum—brain cancer	0.0034	0.0168	CbGeAlD
Boceprevir—CTSV—brain—brain cancer	0.00338	0.0167	CbGeAlD
Boceprevir—CTSS—gonad—brain cancer	0.00337	0.0166	CbGeAlD
Boceprevir—CTSS—pituitary gland—brain cancer	0.00329	0.0162	CbGeAlD
Boceprevir—CTSK—spinal cord—brain cancer	0.00323	0.0159	CbGeAlD
Boceprevir—CTSS—medulla oblongata—brain cancer	0.00317	0.0157	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—BSG—brain cancer	0.00305	0.0237	CbGpPWpGaD
Boceprevir—CTSK—endocrine gland—brain cancer	0.00291	0.0143	CbGeAlD
Boceprevir—CTSS—midbrain—brain cancer	0.0029	0.0143	CbGeAlD
Boceprevir—CTSK—head—brain cancer	0.00287	0.0142	CbGeAlD
Boceprevir—CTSS—spinal cord—brain cancer	0.00283	0.014	CbGeAlD
Boceprevir—CTSL—brain—brain cancer	0.00276	0.0136	CbGeAlD
Boceprevir—CTSK—central nervous system—brain cancer	0.00262	0.0129	CbGeAlD
Boceprevir—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00259	0.0201	CbGpPWpGaD
Boceprevir—CTSK—cerebellum—brain cancer	0.00256	0.0126	CbGeAlD
Boceprevir—CTSS—endocrine gland—brain cancer	0.00255	0.0126	CbGeAlD
Boceprevir—CTSS—head—brain cancer	0.00251	0.0124	CbGeAlD
Boceprevir—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00249	0.0194	CbGpPWpGaD
Boceprevir—CTSS—central nervous system—brain cancer	0.0023	0.0113	CbGeAlD
Boceprevir—CTSV—Endochondral Ossification—SPP1—brain cancer	0.00227	0.0177	CbGpPWpGaD
Boceprevir—CTSS—cerebellum—brain cancer	0.00224	0.0111	CbGeAlD
Boceprevir—CTSK—brain—brain cancer	0.00208	0.0103	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—PCNA—brain cancer	0.00203	0.0158	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—BSG—brain cancer	0.00187	0.0146	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—BSG—brain cancer	0.00187	0.0146	CbGpPWpGaD
Boceprevir—CTSS—brain—brain cancer	0.00182	0.00899	CbGeAlD
Boceprevir—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00178	0.0138	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—SPP1—brain cancer	0.00175	0.0136	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—SPP1—brain cancer	0.00175	0.0136	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—BSG—brain cancer	0.00174	0.0135	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—SPP1—brain cancer	0.00162	0.0126	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—BSG—brain cancer	0.00155	0.0121	CbGpPWpGaD
Boceprevir—ABCB1—blood vessel—brain cancer	0.00147	0.00725	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—SPP1—brain cancer	0.00145	0.0113	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—VAV1—brain cancer	0.00141	0.011	CbGpPWpGaD
Boceprevir—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00134	0.0104	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—RELA—brain cancer	0.00133	0.0103	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—BSG—brain cancer	0.00128	0.00994	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00128	0.00993	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—SKP2—brain cancer	0.00125	0.00975	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—SKP2—brain cancer	0.00125	0.00975	CbGpPWpGaD
Boceprevir—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.0012	0.00936	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—SPP1—brain cancer	0.00119	0.00926	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PDGFRA—brain cancer	0.00116	0.009	CbGpPWpGaD
Boceprevir—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00116	0.009	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—CTNNB1—brain cancer	0.00112	0.00873	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—VEGFA—brain cancer	0.00109	0.00844	CbGpPWpGaD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00107	0.00836	CbGpPWpGaD
Boceprevir—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00106	0.00825	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IRS2—brain cancer	0.00102	0.0079	CbGpPWpGaD
Boceprevir—CMA1—Peptide hormone metabolism—CTNNB1—brain cancer	0.000913	0.00711	CbGpPWpGaD
Boceprevir—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000912	0.0071	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000871	0.00677	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—SKP2—brain cancer	0.000855	0.00665	CbGpPWpGaD
Boceprevir—CYP3A5—endocrine gland—brain cancer	0.000846	0.00418	CbGeAlD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000826	0.00642	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000787	0.00612	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—RELA—brain cancer	0.000754	0.00586	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—RELA—brain cancer	0.000754	0.00586	CbGpPWpGaD
Boceprevir—Weight decreased—Temozolomide—brain cancer	0.000754	0.00208	CcSEcCtD
Boceprevir—Neuropathy peripheral—Carmustine—brain cancer	0.000753	0.00208	CcSEcCtD
Boceprevir—Hyperglycaemia—Temozolomide—brain cancer	0.000751	0.00207	CcSEcCtD
Boceprevir—Stomatitis—Carmustine—brain cancer	0.000749	0.00207	CcSEcCtD
Boceprevir—Urinary tract infection—Carmustine—brain cancer	0.000747	0.00206	CcSEcCtD
Boceprevir—Pneumonia—Temozolomide—brain cancer	0.000747	0.00206	CcSEcCtD
Boceprevir—Erythema—Hydroxyurea—brain cancer	0.000743	0.00205	CcSEcCtD
Boceprevir—Infestation NOS—Temozolomide—brain cancer	0.000743	0.00205	CcSEcCtD
Boceprevir—Infestation—Temozolomide—brain cancer	0.000743	0.00205	CcSEcCtD
Boceprevir—Depression—Temozolomide—brain cancer	0.000741	0.00204	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000736	0.00203	CcSEcCtD
Boceprevir—Nausea—Lomustine—brain cancer	0.000733	0.00202	CcSEcCtD
Boceprevir—Hypotension—Procarbazine—brain cancer	0.000732	0.00202	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—SPP1—brain cancer	0.000731	0.00569	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—SPP1—brain cancer	0.000731	0.00569	CbGpPWpGaD
Boceprevir—Neuropathy peripheral—Temozolomide—brain cancer	0.000728	0.00201	CcSEcCtD
Boceprevir—Stomatitis—Temozolomide—brain cancer	0.000724	0.002	CcSEcCtD
Boceprevir—Urinary tract infection—Temozolomide—brain cancer	0.000722	0.00199	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—OR4C12—brain cancer	0.000718	0.00559	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—OR14C36—brain cancer	0.000718	0.00559	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000714	0.00197	CcSEcCtD
Boceprevir—ABCB1—telencephalon—brain cancer	0.000712	0.00352	CbGeAlD
Boceprevir—Insomnia—Procarbazine—brain cancer	0.000709	0.00195	CcSEcCtD
Boceprevir—Paraesthesia—Procarbazine—brain cancer	0.000703	0.00194	CcSEcCtD
Boceprevir—Hepatobiliary disease—Temozolomide—brain cancer	0.000702	0.00194	CcSEcCtD
Boceprevir—Sinusitis—Temozolomide—brain cancer	0.000697	0.00192	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB2—brain cancer	0.000696	0.00542	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Hydroxyurea—brain cancer	0.000689	0.0019	CcSEcCtD
Boceprevir—Anaemia—Hydroxyurea—brain cancer	0.000687	0.00189	CcSEcCtD
Boceprevir—Hypoaesthesia—Carmustine—brain cancer	0.000686	0.00189	CcSEcCtD
Boceprevir—Decreased appetite—Procarbazine—brain cancer	0.000681	0.00188	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—SPP1—brain cancer	0.00068	0.00529	CbGpPWpGaD
Boceprevir—Oedema peripheral—Carmustine—brain cancer	0.00068	0.00187	CcSEcCtD
Boceprevir—Connective tissue disorder—Carmustine—brain cancer	0.000678	0.00187	CcSEcCtD
Boceprevir—Fatigue—Procarbazine—brain cancer	0.000675	0.00186	CcSEcCtD
Boceprevir—Malaise—Hydroxyurea—brain cancer	0.00067	0.00185	CcSEcCtD
Boceprevir—Pain—Procarbazine—brain cancer	0.00067	0.00185	CcSEcCtD
Boceprevir—Constipation—Procarbazine—brain cancer	0.00067	0.00185	CcSEcCtD
Boceprevir—Dysphagia—Etoposide—brain cancer	0.000666	0.00184	CcSEcCtD
Boceprevir—Leukopenia—Hydroxyurea—brain cancer	0.000665	0.00183	CcSEcCtD
Boceprevir—Visual impairment—Carmustine—brain cancer	0.000665	0.00183	CcSEcCtD
Boceprevir—Hypoaesthesia—Temozolomide—brain cancer	0.000663	0.00183	CcSEcCtD
Boceprevir—Pharyngitis—Temozolomide—brain cancer	0.000662	0.00183	CcSEcCtD
Boceprevir—Urinary tract disorder—Temozolomide—brain cancer	0.000658	0.00182	CcSEcCtD
Boceprevir—Oedema peripheral—Temozolomide—brain cancer	0.000657	0.00181	CcSEcCtD
Boceprevir—Connective tissue disorder—Temozolomide—brain cancer	0.000655	0.00181	CcSEcCtD
Boceprevir—Urethral disorder—Temozolomide—brain cancer	0.000654	0.0018	CcSEcCtD
Boceprevir—Feeling abnormal—Procarbazine—brain cancer	0.000646	0.00178	CcSEcCtD
Boceprevir—Eye disorder—Carmustine—brain cancer	0.000645	0.00178	CcSEcCtD
Boceprevir—Visual impairment—Temozolomide—brain cancer	0.000642	0.00177	CcSEcCtD
Boceprevir—Gastrointestinal pain—Procarbazine—brain cancer	0.000641	0.00177	CcSEcCtD
Boceprevir—Flushing—Carmustine—brain cancer	0.00064	0.00177	CcSEcCtD
Boceprevir—CYP3A4—endocrine gland—brain cancer	0.000635	0.00313	CbGeAlD
Boceprevir—Pancytopenia—Etoposide—brain cancer	0.000633	0.00175	CcSEcCtD
Boceprevir—Erythema multiforme—Temozolomide—brain cancer	0.00063	0.00174	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000628	0.00173	CcSEcCtD
Boceprevir—Discomfort—Hydroxyurea—brain cancer	0.000625	0.00172	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—RELA—brain cancer	0.000625	0.00486	CbGpPWpGaD
Boceprevir—Neutropenia—Etoposide—brain cancer	0.000623	0.00172	CcSEcCtD
Boceprevir—Eye disorder—Temozolomide—brain cancer	0.000623	0.00172	CcSEcCtD
Boceprevir—Urticaria—Procarbazine—brain cancer	0.000622	0.00172	CcSEcCtD
Boceprevir—Tinnitus—Temozolomide—brain cancer	0.000622	0.00171	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—SKP2—brain cancer	0.00062	0.00482	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SKP2—brain cancer	0.00062	0.00482	CbGpPWpGaD
Boceprevir—Abdominal pain—Procarbazine—brain cancer	0.000619	0.00171	CcSEcCtD
Boceprevir—Body temperature increased—Procarbazine—brain cancer	0.000619	0.00171	CcSEcCtD
Boceprevir—Cardiac disorder—Temozolomide—brain cancer	0.000619	0.00171	CcSEcCtD
Boceprevir—Flushing—Temozolomide—brain cancer	0.000619	0.00171	CcSEcCtD
Boceprevir—Arrhythmia—Carmustine—brain cancer	0.000616	0.0017	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—DTX2—brain cancer	0.000611	0.00475	CbGpPWpGaD
Boceprevir—Alopecia—Carmustine—brain cancer	0.00061	0.00168	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—SPP1—brain cancer	0.000606	0.00471	CbGpPWpGaD
Boceprevir—Angiopathy—Temozolomide—brain cancer	0.000605	0.00167	CcSEcCtD
Boceprevir—Mental disorder—Carmustine—brain cancer	0.000604	0.00167	CcSEcCtD
Boceprevir—Infection—Hydroxyurea—brain cancer	0.000602	0.00166	CcSEcCtD
Boceprevir—Immune system disorder—Temozolomide—brain cancer	0.000602	0.00166	CcSEcCtD
Boceprevir—Mediastinal disorder—Temozolomide—brain cancer	0.000601	0.00166	CcSEcCtD
Boceprevir—Erythema—Carmustine—brain cancer	0.000601	0.00166	CcSEcCtD
Boceprevir—Malnutrition—Carmustine—brain cancer	0.000601	0.00166	CcSEcCtD
Boceprevir—Chills—Temozolomide—brain cancer	0.000598	0.00165	CcSEcCtD
Boceprevir—Pneumonia—Etoposide—brain cancer	0.000598	0.00165	CcSEcCtD
Boceprevir—Nervous system disorder—Hydroxyurea—brain cancer	0.000595	0.00164	CcSEcCtD
Boceprevir—ABCB1—gonad—brain cancer	0.000595	0.00293	CbGeAlD
Boceprevir—Infestation—Etoposide—brain cancer	0.000594	0.00164	CcSEcCtD
Boceprevir—Infestation NOS—Etoposide—brain cancer	0.000594	0.00164	CcSEcCtD
Boceprevir—Thrombocytopenia—Hydroxyurea—brain cancer	0.000594	0.00164	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000589	0.00163	CcSEcCtD
Boceprevir—Alopecia—Temozolomide—brain cancer	0.000589	0.00162	CcSEcCtD
Boceprevir—Skin disorder—Hydroxyurea—brain cancer	0.000589	0.00162	CcSEcCtD
Boceprevir—Mental disorder—Temozolomide—brain cancer	0.000584	0.00161	CcSEcCtD
Boceprevir—Neuropathy peripheral—Etoposide—brain cancer	0.000583	0.00161	CcSEcCtD
Boceprevir—Back pain—Carmustine—brain cancer	0.000581	0.0016	CcSEcCtD
Boceprevir—Erythema—Temozolomide—brain cancer	0.00058	0.0016	CcSEcCtD
Boceprevir—Malnutrition—Temozolomide—brain cancer	0.00058	0.0016	CcSEcCtD
Boceprevir—ABCB1—pituitary gland—brain cancer	0.00058	0.00286	CbGeAlD
Boceprevir—Stomatitis—Etoposide—brain cancer	0.000579	0.0016	CcSEcCtD
Boceprevir—Hypersensitivity—Procarbazine—brain cancer	0.000577	0.00159	CcSEcCtD
Boceprevir—CYP3A4—central nervous system—brain cancer	0.000572	0.00282	CbGeAlD
Boceprevir—Dysgeusia—Temozolomide—brain cancer	0.000568	0.00157	CcSEcCtD
Boceprevir—Vision blurred—Carmustine—brain cancer	0.000566	0.00156	CcSEcCtD
Boceprevir—Asthenia—Procarbazine—brain cancer	0.000562	0.00155	CcSEcCtD
Boceprevir—Hepatobiliary disease—Etoposide—brain cancer	0.000562	0.00155	CcSEcCtD
Boceprevir—Back pain—Temozolomide—brain cancer	0.000561	0.00155	CcSEcCtD
Boceprevir—ABCB1—medulla oblongata—brain cancer	0.00056	0.00276	CbGeAlD
Boceprevir—Anaemia—Carmustine—brain cancer	0.000555	0.00153	CcSEcCtD
Boceprevir—Agranulocytosis—Etoposide—brain cancer	0.000555	0.00153	CcSEcCtD
Boceprevir—Pruritus—Procarbazine—brain cancer	0.000554	0.00153	CcSEcCtD
Boceprevir—Agitation—Carmustine—brain cancer	0.000552	0.00152	CcSEcCtD
Boceprevir—Vision blurred—Temozolomide—brain cancer	0.000547	0.00151	CcSEcCtD
Boceprevir—Dyspnoea—Hydroxyurea—brain cancer	0.000541	0.00149	CcSEcCtD
Boceprevir—Ill-defined disorder—Temozolomide—brain cancer	0.000538	0.00149	CcSEcCtD
Boceprevir—Leukopenia—Carmustine—brain cancer	0.000538	0.00148	CcSEcCtD
Boceprevir—Anaemia—Temozolomide—brain cancer	0.000536	0.00148	CcSEcCtD
Boceprevir—Diarrhoea—Procarbazine—brain cancer	0.000536	0.00148	CcSEcCtD
Boceprevir—Dyspepsia—Hydroxyurea—brain cancer	0.000534	0.00147	CcSEcCtD
Boceprevir—Agitation—Temozolomide—brain cancer	0.000533	0.00147	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—STAT3—brain cancer	0.000531	0.00413	CbGpPWpGaD
Boceprevir—Hypoaesthesia—Etoposide—brain cancer	0.000531	0.00146	CcSEcCtD
Boceprevir—Angioedema—Temozolomide—brain cancer	0.00053	0.00146	CcSEcCtD
Boceprevir—Decreased appetite—Hydroxyurea—brain cancer	0.000527	0.00145	CcSEcCtD
Boceprevir—Urinary tract disorder—Etoposide—brain cancer	0.000527	0.00145	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000523	0.00144	CcSEcCtD
Boceprevir—Malaise—Temozolomide—brain cancer	0.000523	0.00144	CcSEcCtD
Boceprevir—Urethral disorder—Etoposide—brain cancer	0.000523	0.00144	CcSEcCtD
Boceprevir—Fatigue—Hydroxyurea—brain cancer	0.000523	0.00144	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000522	0.00406	CbGpPWpGaD
Boceprevir—Vertigo—Temozolomide—brain cancer	0.000521	0.00144	CcSEcCtD
Boceprevir—Leukopenia—Temozolomide—brain cancer	0.000519	0.00143	CcSEcCtD
Boceprevir—Hypertension—Carmustine—brain cancer	0.000518	0.00143	CcSEcCtD
Boceprevir—Pain—Hydroxyurea—brain cancer	0.000518	0.00143	CcSEcCtD
Boceprevir—Constipation—Hydroxyurea—brain cancer	0.000518	0.00143	CcSEcCtD
Boceprevir—Dizziness—Procarbazine—brain cancer	0.000518	0.00143	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—RELA—brain cancer	0.000514	0.004	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SKP2—brain cancer	0.000514	0.004	CbGpPWpGaD
Boceprevir—Palpitations—Temozolomide—brain cancer	0.000513	0.00141	CcSEcCtD
Boceprevir—ABCB1—midbrain—brain cancer	0.000512	0.00253	CbGeAlD
Boceprevir—Chest pain—Carmustine—brain cancer	0.000511	0.00141	CcSEcCtD
Boceprevir—Myalgia—Carmustine—brain cancer	0.000511	0.00141	CcSEcCtD
Boceprevir—Anxiety—Carmustine—brain cancer	0.00051	0.00141	CcSEcCtD
Boceprevir—Cough—Temozolomide—brain cancer	0.000506	0.0014	CcSEcCtD
Boceprevir—Erythema multiforme—Etoposide—brain cancer	0.000504	0.00139	CcSEcCtD
Boceprevir—Hypertension—Temozolomide—brain cancer	0.000501	0.00138	CcSEcCtD
Boceprevir—Feeling abnormal—Hydroxyurea—brain cancer	0.0005	0.00138	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000499	0.00389	CbGpPWpGaD
Boceprevir—ABCB1—spinal cord—brain cancer	0.000499	0.00246	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—SPP1—brain cancer	0.000499	0.00388	CbGpPWpGaD
Boceprevir—Eye disorder—Etoposide—brain cancer	0.000499	0.00138	CcSEcCtD
Boceprevir—Vomiting—Procarbazine—brain cancer	0.000498	0.00137	CcSEcCtD
Boceprevir—Flushing—Etoposide—brain cancer	0.000495	0.00137	CcSEcCtD
Boceprevir—Cardiac disorder—Etoposide—brain cancer	0.000495	0.00137	CcSEcCtD
Boceprevir—Confusional state—Carmustine—brain cancer	0.000494	0.00136	CcSEcCtD
Boceprevir—Myalgia—Temozolomide—brain cancer	0.000494	0.00136	CcSEcCtD
Boceprevir—Arthralgia—Temozolomide—brain cancer	0.000494	0.00136	CcSEcCtD
Boceprevir—Rash—Procarbazine—brain cancer	0.000494	0.00136	CcSEcCtD
Boceprevir—Dermatitis—Procarbazine—brain cancer	0.000493	0.00136	CcSEcCtD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000493	0.00383	CbGpPWpGaD
Boceprevir—Anxiety—Temozolomide—brain cancer	0.000492	0.00136	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—VAV1—brain cancer	0.000492	0.00383	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—VAV1—brain cancer	0.000492	0.00383	CbGpPWpGaD
Boceprevir—Headache—Procarbazine—brain cancer	0.000491	0.00135	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000491	0.00135	CcSEcCtD
Boceprevir—Discomfort—Temozolomide—brain cancer	0.000488	0.00135	CcSEcCtD
Boceprevir—Infection—Carmustine—brain cancer	0.000487	0.00134	CcSEcCtD
Boceprevir—Angiopathy—Etoposide—brain cancer	0.000484	0.00134	CcSEcCtD
Boceprevir—Dry mouth—Temozolomide—brain cancer	0.000483	0.00133	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—brain cancer	0.000483	0.00375	CbGpPWpGaD
Boceprevir—Immune system disorder—Etoposide—brain cancer	0.000482	0.00133	CcSEcCtD
Boceprevir—Mediastinal disorder—Etoposide—brain cancer	0.000481	0.00133	CcSEcCtD
Boceprevir—Thrombocytopenia—Carmustine—brain cancer	0.00048	0.00132	CcSEcCtD
Boceprevir—Body temperature increased—Hydroxyurea—brain cancer	0.000479	0.00132	CcSEcCtD
Boceprevir—Chills—Etoposide—brain cancer	0.000479	0.00132	CcSEcCtD
Boceprevir—Tachycardia—Carmustine—brain cancer	0.000478	0.00132	CcSEcCtD
Boceprevir—Confusional state—Temozolomide—brain cancer	0.000478	0.00132	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—VAV1—brain cancer	0.000473	0.00368	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—VAV1—brain cancer	0.000473	0.00368	CbGpPWpGaD
Boceprevir—Alopecia—Etoposide—brain cancer	0.000471	0.0013	CcSEcCtD
Boceprevir—Infection—Temozolomide—brain cancer	0.000471	0.0013	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000465	0.00362	CbGpPWpGaD
Boceprevir—Nausea—Procarbazine—brain cancer	0.000465	0.00128	CcSEcCtD
Boceprevir—Nervous system disorder—Temozolomide—brain cancer	0.000464	0.00128	CcSEcCtD
Boceprevir—Thrombocytopenia—Temozolomide—brain cancer	0.000464	0.00128	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTCH2—brain cancer	0.000463	0.0036	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000463	0.0036	CbGpPWpGaD
Boceprevir—Skin disorder—Temozolomide—brain cancer	0.00046	0.00127	CcSEcCtD
Boceprevir—Hypotension—Carmustine—brain cancer	0.000458	0.00126	CcSEcCtD
Boceprevir—Hyperhidrosis—Temozolomide—brain cancer	0.000458	0.00126	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000456	0.00355	CbGpPWpGaD
Boceprevir—Dysgeusia—Etoposide—brain cancer	0.000455	0.00125	CcSEcCtD
Boceprevir—ABCB1—endocrine gland—brain cancer	0.000449	0.00222	CbGeAlD
Boceprevir—Back pain—Etoposide—brain cancer	0.000449	0.00124	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—HES5—brain cancer	0.000448	0.00349	CbGpPWpGaD
Boceprevir—Hypersensitivity—Hydroxyurea—brain cancer	0.000447	0.00123	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Carmustine—brain cancer	0.000447	0.00123	CcSEcCtD
Boceprevir—Muscle spasms—Etoposide—brain cancer	0.000446	0.00123	CcSEcCtD
Boceprevir—ABCB1—head—brain cancer	0.000444	0.00219	CbGeAlD
Boceprevir—Insomnia—Carmustine—brain cancer	0.000443	0.00122	CcSEcCtD
Boceprevir—Paraesthesia—Carmustine—brain cancer	0.00044	0.00121	CcSEcCtD
Boceprevir—Dyspnoea—Carmustine—brain cancer	0.000437	0.00121	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—STRADA—brain cancer	0.000435	0.00339	CbGpPWpGaD
Boceprevir—Asthenia—Hydroxyurea—brain cancer	0.000435	0.0012	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000432	0.00119	CcSEcCtD
Boceprevir—Ill-defined disorder—Etoposide—brain cancer	0.000431	0.00119	CcSEcCtD
Boceprevir—Anaemia—Etoposide—brain cancer	0.000429	0.00118	CcSEcCtD
Boceprevir—Insomnia—Temozolomide—brain cancer	0.000428	0.00118	CcSEcCtD
Boceprevir—Decreased appetite—Carmustine—brain cancer	0.000426	0.00118	CcSEcCtD
Boceprevir—Paraesthesia—Temozolomide—brain cancer	0.000425	0.00117	CcSEcCtD
Boceprevir—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000424	0.0033	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Carmustine—brain cancer	0.000423	0.00117	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—SKP2—brain cancer	0.000423	0.00329	CbGpPWpGaD
Boceprevir—Dyspnoea—Temozolomide—brain cancer	0.000422	0.00116	CcSEcCtD
Boceprevir—Constipation—Carmustine—brain cancer	0.000419	0.00116	CcSEcCtD
Boceprevir—Pain—Carmustine—brain cancer	0.000419	0.00116	CcSEcCtD
Boceprevir—Malaise—Etoposide—brain cancer	0.000419	0.00116	CcSEcCtD
Boceprevir—Vertigo—Etoposide—brain cancer	0.000417	0.00115	CcSEcCtD
Boceprevir—Dyspepsia—Temozolomide—brain cancer	0.000417	0.00115	CcSEcCtD
Boceprevir—Leukopenia—Etoposide—brain cancer	0.000416	0.00115	CcSEcCtD
Boceprevir—Diarrhoea—Hydroxyurea—brain cancer	0.000415	0.00114	CcSEcCtD
Boceprevir—Decreased appetite—Temozolomide—brain cancer	0.000412	0.00114	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000409	0.00113	CcSEcCtD
Boceprevir—Fatigue—Temozolomide—brain cancer	0.000408	0.00113	CcSEcCtD
Boceprevir—Loss of consciousness—Etoposide—brain cancer	0.000408	0.00113	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—VAV1—brain cancer	0.000408	0.00317	CbGpPWpGaD
Boceprevir—Cough—Etoposide—brain cancer	0.000405	0.00112	CcSEcCtD
Boceprevir—Pain—Temozolomide—brain cancer	0.000405	0.00112	CcSEcCtD
Boceprevir—Constipation—Temozolomide—brain cancer	0.000405	0.00112	CcSEcCtD
Boceprevir—ABCB1—central nervous system—brain cancer	0.000405	0.002	CbGeAlD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000405	0.00315	CbGpPWpGaD
Boceprevir—Feeling abnormal—Carmustine—brain cancer	0.000404	0.00111	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—PDGFRA—brain cancer	0.000403	0.00314	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PDGFRA—brain cancer	0.000403	0.00314	CbGpPWpGaD
Boceprevir—Hypertension—Etoposide—brain cancer	0.000401	0.00111	CcSEcCtD
Boceprevir—Dizziness—Hydroxyurea—brain cancer	0.000401	0.00111	CcSEcCtD
Boceprevir—Gastrointestinal pain—Carmustine—brain cancer	0.000401	0.00111	CcSEcCtD
Boceprevir—ABCB1—cerebellum—brain cancer	0.000396	0.00195	CbGeAlD
Boceprevir—Chest pain—Etoposide—brain cancer	0.000395	0.00109	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000393	0.00108	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—VAV1—brain cancer	0.000392	0.00305	CbGpPWpGaD
Boceprevir—Discomfort—Etoposide—brain cancer	0.000391	0.00108	CcSEcCtD
Boceprevir—Feeling abnormal—Temozolomide—brain cancer	0.00039	0.00108	CcSEcCtD
Boceprevir—Abdominal pain—Carmustine—brain cancer	0.000387	0.00107	CcSEcCtD
Boceprevir—Body temperature increased—Carmustine—brain cancer	0.000387	0.00107	CcSEcCtD
Boceprevir—Gastrointestinal pain—Temozolomide—brain cancer	0.000387	0.00107	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—PDGFRA—brain cancer	0.000387	0.00301	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PDGFRA—brain cancer	0.000387	0.00301	CbGpPWpGaD
Boceprevir—Vomiting—Hydroxyurea—brain cancer	0.000385	0.00106	CcSEcCtD
Boceprevir—Rash—Hydroxyurea—brain cancer	0.000382	0.00105	CcSEcCtD
Boceprevir—Confusional state—Etoposide—brain cancer	0.000382	0.00105	CcSEcCtD
Boceprevir—Dermatitis—Hydroxyurea—brain cancer	0.000382	0.00105	CcSEcCtD
Boceprevir—Headache—Hydroxyurea—brain cancer	0.00038	0.00105	CcSEcCtD
Boceprevir—Infection—Etoposide—brain cancer	0.000377	0.00104	CcSEcCtD
Boceprevir—Urticaria—Temozolomide—brain cancer	0.000376	0.00104	CcSEcCtD
Boceprevir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000376	0.00293	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SKP2—brain cancer	0.000376	0.00293	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SKP2—brain cancer	0.000376	0.00293	CbGpPWpGaD
Boceprevir—Body temperature increased—Temozolomide—brain cancer	0.000374	0.00103	CcSEcCtD
Boceprevir—Abdominal pain—Temozolomide—brain cancer	0.000374	0.00103	CcSEcCtD
Boceprevir—Thrombocytopenia—Etoposide—brain cancer	0.000371	0.00102	CcSEcCtD
Boceprevir—Tachycardia—Etoposide—brain cancer	0.00037	0.00102	CcSEcCtD
Boceprevir—Skin disorder—Etoposide—brain cancer	0.000368	0.00102	CcSEcCtD
Boceprevir—Hyperhidrosis—Etoposide—brain cancer	0.000366	0.00101	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ABR—brain cancer	0.000363	0.00283	CbGpPWpGaD
Boceprevir—Hypersensitivity—Carmustine—brain cancer	0.000361	0.000996	CcSEcCtD
Boceprevir—Nausea—Hydroxyurea—brain cancer	0.00036	0.000993	CcSEcCtD
Boceprevir—Hypotension—Etoposide—brain cancer	0.000354	0.000977	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—IRS2—brain cancer	0.000354	0.00275	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IRS2—brain cancer	0.000354	0.00275	CbGpPWpGaD
Boceprevir—Asthenia—Carmustine—brain cancer	0.000352	0.00097	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GLI2—brain cancer	0.000351	0.00273	CbGpPWpGaD
Boceprevir—Hypersensitivity—Temozolomide—brain cancer	0.000349	0.000963	CcSEcCtD
Boceprevir—Paraesthesia—Etoposide—brain cancer	0.00034	0.000939	CcSEcCtD
Boceprevir—Asthenia—Temozolomide—brain cancer	0.00034	0.000937	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—IRS2—brain cancer	0.00034	0.00264	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—IRS2—brain cancer	0.00034	0.00264	CbGpPWpGaD
Boceprevir—Dyspnoea—Etoposide—brain cancer	0.000338	0.000932	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—VAV1—brain cancer	0.000336	0.00261	CbGpPWpGaD
Boceprevir—Diarrhoea—Carmustine—brain cancer	0.000335	0.000925	CcSEcCtD
Boceprevir—Pruritus—Temozolomide—brain cancer	0.000335	0.000924	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—PDGFRA—brain cancer	0.000334	0.0026	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GLI1—brain cancer	0.00033	0.00257	CbGpPWpGaD
Boceprevir—Decreased appetite—Etoposide—brain cancer	0.000329	0.000909	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Etoposide—brain cancer	0.000327	0.000903	CcSEcCtD
Boceprevir—Fatigue—Etoposide—brain cancer	0.000327	0.000901	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000326	0.00254	CbGpPWpGaD
Boceprevir—Dizziness—Carmustine—brain cancer	0.000324	0.000894	CcSEcCtD
Boceprevir—Constipation—Etoposide—brain cancer	0.000324	0.000894	CcSEcCtD
Boceprevir—Pain—Etoposide—brain cancer	0.000324	0.000894	CcSEcCtD
Boceprevir—Diarrhoea—Temozolomide—brain cancer	0.000324	0.000894	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—VAV1—brain cancer	0.000322	0.00251	CbGpPWpGaD
Boceprevir—ABCB1—brain—brain cancer	0.000321	0.00159	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—PDGFRA—brain cancer	0.000321	0.00249	CbGpPWpGaD
Boceprevir—Dizziness—Temozolomide—brain cancer	0.000313	0.000864	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SUFU—brain cancer	0.000313	0.00243	CbGpPWpGaD
Boceprevir—Feeling abnormal—Etoposide—brain cancer	0.000312	0.000861	CcSEcCtD
Boceprevir—CTSK—Immune System—SKP2—brain cancer	0.000312	0.00242	CbGpPWpGaD
Boceprevir—Vomiting—Carmustine—brain cancer	0.000312	0.00086	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—brain cancer	0.00031	0.000855	CcSEcCtD
Boceprevir—Rash—Carmustine—brain cancer	0.000309	0.000852	CcSEcCtD
Boceprevir—Dermatitis—Carmustine—brain cancer	0.000309	0.000852	CcSEcCtD
Boceprevir—Headache—Carmustine—brain cancer	0.000307	0.000847	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GFAP—brain cancer	0.000302	0.00235	CbGpPWpGaD
Boceprevir—Vomiting—Temozolomide—brain cancer	0.000301	0.000831	CcSEcCtD
Boceprevir—Urticaria—Etoposide—brain cancer	0.000301	0.00083	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—brain cancer	0.0003	0.000826	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—brain cancer	0.0003	0.000826	CcSEcCtD
Boceprevir—Rash—Temozolomide—brain cancer	0.000299	0.000824	CcSEcCtD
Boceprevir—Dermatitis—Temozolomide—brain cancer	0.000298	0.000823	CcSEcCtD
Boceprevir—Headache—Temozolomide—brain cancer	0.000297	0.000818	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IRS2—brain cancer	0.000293	0.00228	CbGpPWpGaD
Boceprevir—Nausea—Carmustine—brain cancer	0.000291	0.000803	CcSEcCtD
Boceprevir—CTSL—Immune System—VAV1—brain cancer	0.000287	0.00223	CbGpPWpGaD
Boceprevir—CTSV—Immune System—VAV1—brain cancer	0.000287	0.00223	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HEY1—brain cancer	0.000286	0.00222	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—IRS2—brain cancer	0.000282	0.00219	CbGpPWpGaD
Boceprevir—Nausea—Temozolomide—brain cancer	0.000281	0.000776	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—DLL1—brain cancer	0.00028	0.00218	CbGpPWpGaD
Boceprevir—Hypersensitivity—Etoposide—brain cancer	0.000279	0.00077	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PDGFRA—brain cancer	0.000275	0.00214	CbGpPWpGaD
Boceprevir—Asthenia—Etoposide—brain cancer	0.000272	0.00075	CcSEcCtD
Boceprevir—Pruritus—Etoposide—brain cancer	0.000268	0.00074	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PDGFRA—brain cancer	0.000264	0.00205	CbGpPWpGaD
Boceprevir—Diarrhoea—Etoposide—brain cancer	0.000259	0.000715	CcSEcCtD
Boceprevir—CTSS—Immune System—SKP2—brain cancer	0.000257	0.002	CbGpPWpGaD
Boceprevir—Dizziness—Etoposide—brain cancer	0.000251	0.000691	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—RELA—brain cancer	0.000244	0.0019	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—RELA—brain cancer	0.000244	0.0019	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—brain cancer	0.000243	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB2—brain cancer	0.000243	0.00189	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IRS2—brain cancer	0.000241	0.00188	CbGpPWpGaD
Boceprevir—Vomiting—Etoposide—brain cancer	0.000241	0.000665	CcSEcCtD
Boceprevir—Rash—Etoposide—brain cancer	0.000239	0.000659	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—brain cancer	0.000239	0.000659	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SHH—brain cancer	0.000238	0.00186	CbGpPWpGaD
Boceprevir—CTSK—Immune System—VAV1—brain cancer	0.000238	0.00185	CbGpPWpGaD
Boceprevir—Headache—Etoposide—brain cancer	0.000237	0.000655	CcSEcCtD
Boceprevir—CTSV—Immune System—PDGFRA—brain cancer	0.000235	0.00183	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PDGFRA—brain cancer	0.000235	0.00183	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—RELA—brain cancer	0.000234	0.00182	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RELA—brain cancer	0.000234	0.00182	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—brain cancer	0.000233	0.00181	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—brain cancer	0.000233	0.00181	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—IRS2—brain cancer	0.000232	0.0018	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TRPC6—brain cancer	0.00023	0.00179	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTCH1—brain cancer	0.000226	0.00176	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SMO—brain cancer	0.000226	0.00176	CbGpPWpGaD
Boceprevir—Nausea—Etoposide—brain cancer	0.000225	0.000621	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000222	0.00173	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000215	0.00167	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTNNB1—brain cancer	0.000212	0.00165	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CTNNB1—brain cancer	0.000212	0.00165	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000212	0.00165	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IRS2—brain cancer	0.000206	0.0016	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IRS2—brain cancer	0.000206	0.0016	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—RELA—brain cancer	0.000202	0.00157	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB2—brain cancer	0.000201	0.00156	CbGpPWpGaD
Boceprevir—CTSS—Immune System—VAV1—brain cancer	0.000196	0.00152	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PDGFRA—brain cancer	0.000194	0.00151	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—RELA—brain cancer	0.000194	0.00151	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—brain cancer	0.000193	0.0015	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000186	0.00144	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH2—brain cancer	0.000181	0.00141	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CTNNB1—brain cancer	0.000176	0.00137	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000176	0.00137	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CTNNB1—brain cancer	0.000172	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VAV1—brain cancer	0.000172	0.00134	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IRS2—brain cancer	0.000171	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—brain cancer	0.000168	0.00131	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—brain cancer	0.000168	0.00131	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RELA—brain cancer	0.000167	0.0013	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB2—brain cancer	0.000166	0.00129	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—brain cancer	0.000161	0.00126	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—brain cancer	0.000161	0.00126	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PDGFRA—brain cancer	0.00016	0.00125	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RELA—brain cancer	0.00016	0.00124	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—brain cancer	0.000159	0.00124	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000154	0.0012	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000148	0.00115	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HES1—brain cancer	0.000148	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTNNB1—brain cancer	0.000145	0.00113	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RELA—brain cancer	0.000142	0.00111	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RELA—brain cancer	0.000142	0.00111	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—brain cancer	0.000141	0.0011	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—brain cancer	0.000141	0.0011	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFRA—brain cancer	0.000141	0.0011	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRS2—brain cancer	0.000141	0.00109	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—brain cancer	0.000139	0.00108	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000139	0.00108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SPP1—brain cancer	0.000137	0.00107	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—brain cancer	0.000134	0.00104	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—brain cancer	0.000128	0.000996	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—brain cancer	0.000128	0.000996	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IRS2—brain cancer	0.000124	0.000964	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTNNB1—brain cancer	0.000124	0.000962	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—brain cancer	0.000124	0.000962	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000122	0.000948	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—brain cancer	0.000121	0.000944	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00012	0.00093	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000119	0.000927	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000118	0.000918	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RELA—brain cancer	0.000118	0.000917	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—brain cancer	0.000117	0.000911	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—brain cancer	0.000115	0.000893	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—brain cancer	0.00011	0.000857	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00011	0.000854	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CG—brain cancer	0.000109	0.000851	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APC—brain cancer	0.000109	0.000851	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—brain cancer	0.000108	0.000838	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—brain cancer	0.000108	0.000838	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—brain cancer	0.000106	0.000826	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000105	0.000814	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000103	0.000802	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—brain cancer	0.000102	0.000797	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—brain cancer	9.8e-05	0.000762	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—brain cancer	9.8e-05	0.000762	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RELA—brain cancer	9.7e-05	0.000755	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—brain cancer	9.64e-05	0.00075	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.04e-05	0.000703	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—brain cancer	8.93e-05	0.000695	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—brain cancer	8.74e-05	0.00068	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RELA—brain cancer	8.55e-05	0.000665	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.51e-05	0.000662	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—brain cancer	8.49e-05	0.000661	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—brain cancer	8.44e-05	0.000656	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—brain cancer	8.12e-05	0.000631	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C9—brain cancer	7.91e-05	0.000615	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—brain cancer	7.7e-05	0.000599	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—brain cancer	7.5e-05	0.000584	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—brain cancer	7.43e-05	0.000578	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—brain cancer	7.35e-05	0.000572	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.1e-05	0.000553	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BSG—brain cancer	6.73e-05	0.000523	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—brain cancer	6.68e-05	0.00052	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.61e-05	0.000514	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—brain cancer	6.54e-05	0.000509	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—brain cancer	6.48e-05	0.000504	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—brain cancer	6.02e-05	0.000468	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C9—brain cancer	5.97e-05	0.000464	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—brain cancer	5.89e-05	0.000458	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.84e-05	0.000454	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH1—brain cancer	5.78e-05	0.00045	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.78e-05	0.00045	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.09e-05	0.000396	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BSG—brain cancer	5.08e-05	0.000395	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—brain cancer	4.94e-05	0.000385	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.68e-05	0.000364	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.58e-05	0.000356	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—brain cancer	4.57e-05	0.000356	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH1—brain cancer	4.36e-05	0.00034	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.85e-05	0.000299	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C9—brain cancer	3.68e-05	0.000286	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—brain cancer	3.45e-05	0.000268	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BSG—brain cancer	3.13e-05	0.000243	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH1—brain cancer	2.69e-05	0.000209	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—brain cancer	2.13e-05	0.000165	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—brain cancer	2.1e-05	0.000163	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—brain cancer	1.58e-05	0.000123	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—brain cancer	9.75e-06	7.59e-05	CbGpPWpGaD
